AQP4 and neuromyelitis optica: It is reported that during the disease attack total hemolytic complement activity (CH50) is increased in sera of NMO patients who are AQP4-IgG seropositive and have extensive CNS lesions in comparison with those who are AQP4-IgG seronegative or with MS patients [31].